A Study of BMS-986449 With and Without Nivolumab in Participants With Advanced Solid Tumors
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Advanced Solid Tumors
Interventions: DRUG: BMS-986449|DRUG: Nivolumab
Sponsor: Bristol-Myers Squibb